Charles River Laboratories International, Inc.
CRL- 交易所
- NYSE
- 產業
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
近 90 天，Charles River Laboratories International, Inc. 內部人申報 1 筆公開市場買進、6 筆賣出；2026 年第 2 季末有 571 家機構在 13F 申報持有，市值合計 $128.6 億；大師中只有Oakmark（Harris Associates）持有。
SEC 申報
Charles River Laboratories International, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/9 | 8-K | 7.019.01 | 2026/11/9 | SEC | 目錄 |
| 2026/11/4 | 10-Q | – | 2026/9/26 | SEC | 目錄 |
| 2026/11/4 | 8-K | 2.029.01 | 2026/11/4 | SEC | 目錄 |
| 2026/9/24 | 8-K | 7.019.01 | 2026/9/24 | SEC | 目錄 |
| 2026/8/5 | 10-Q | – | 2026/6/27 | SEC | 目錄 |
| 2026/8/5 | 8-K | 2.029.01 | 2026/8/5 | SEC | 目錄 |
| 2026/5/11 | 8-K | 5.025.079.01 | 2026/5/5 | SEC | 目錄 |
| 2026/5/7 | 10-Q | – | 2026/3/28 | SEC | 目錄 |
| 2026/5/7 | 8-K | 2.029.01 | 2026/5/7 | SEC | 目錄 |
| 2026/2/25 | 8-K | 7.01 | 2026/2/25 | SEC | 目錄 |
| 2026/2/18 | 10-K | – | 2025/12/27 | SEC | 目錄 |
| 2026/2/18 | 8-K | 2.029.01 | 2026/2/18 | SEC | 目錄 |
| 2026/2/18 | 8-K | 5.029.01 | 2026/2/18 | SEC | 目錄 |
| 2026/1/13 | 8-K | 2.027.01 | 2026/1/13 | SEC | 目錄 |
| 2026/1/9 | 8-K | 5.02 | 2026/1/8 | SEC | 目錄 |
| 2025/12/3 | 8-K | 7.01 | 2025/12/3 | SEC | 目錄 |
| 2025/11/17 | 8-K | 8.01 | 2025/11/14 | SEC | 目錄 |
| 2025/11/5 | 10-Q | – | 2025/9/27 | SEC | 目錄 |
| 2025/11/5 | 8-K | 2.029.01 | 2025/11/5 | SEC | 目錄 |
| 2025/9/19 | 8-K/A | 5.02 | 2025/9/12 | SEC | 目錄 |
| 2025/9/16 | 8-K | 5.027.019.01 | 2025/9/12 | SEC | 目錄 |
| 2025/8/6 | 10-Q | – | 2025/6/28 | SEC | 目錄 |
| 2025/8/6 | 8-K | 2.029.01 | 2025/8/6 | SEC | 目錄 |
| 2025/5/23 | 8-K | 5.025.07 | 2025/5/20 | SEC | 目錄 |
| 2025/5/7 | 10-Q | – | 2025/3/29 | SEC | 目錄 |
| 2025/5/7 | 8-K | 2.029.01 | 2025/5/7 | SEC | 目錄 |
| 2025/5/7 | 8-K | 1.015.027.019.01 | 2025/5/7 | SEC | 目錄 |
| 2025/2/21 | 8-K | 8.01 | 2025/2/20 | SEC | 目錄 |
| 2025/2/19 | 10-K | – | 2024/12/28 | SEC | 目錄 |
| 2025/2/19 | 8-K | 2.029.01 | 2025/2/19 | SEC | 目錄 |
| 2025/1/14 | 8-K | 7.01 | 2025/1/14 | SEC | 目錄 |
| 2024/12/13 | 8-K | 2.039.01 | 2024/12/13 | SEC | 目錄 |
| 2024/11/6 | 10-Q | – | 2024/9/28 | SEC | 目錄 |
| 2024/11/6 | 8-K | 2.029.01 | 2024/11/6 | SEC | 目錄 |
| 2024/8/7 | 10-Q | – | 2024/6/29 | SEC | 目錄 |
| 2024/8/7 | 8-K | 2.029.01 | 2024/8/7 | SEC | 目錄 |
| 2024/5/10 | 8-K | 5.07 | 2024/5/8 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/30 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.029.01 | 2024/5/9 | SEC | 目錄 |
| 2024/2/14 | 8-K | 2.029.01 | 2024/2/14 | SEC | 目錄 |
| 2024/2/14 | 10-K | – | 2023/12/30 | SEC | 目錄 |
| 2024/1/24 | 8-K | 5.02 | 2024/1/22 | SEC | 目錄 |
| 2024/1/16 | 8-K | 5.02 | 2024/1/9 | SEC | 目錄 |
| 2023/11/15 | 8-K | 8.01 | 2023/11/14 | SEC | 目錄 |
| 2023/11/8 | 8-K | 2.029.01 | 2023/11/8 | SEC | 目錄 |
| 2023/11/8 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/8/9 | 8-K | 2.029.01 | 2023/8/9 | SEC | 目錄 |
| 2023/8/9 | 10-Q | – | 2023/7/1 | SEC | 目錄 |
| 2023/5/15 | 8-K | 5.07 | 2023/5/15 | SEC | 目錄 |
| 2023/5/11 | 8-K | 2.029.01 | 2023/5/11 | SEC | 目錄 |